The effects of telmisartan on the nuclear factor of activated T lymphocytes signalling pathway in hypertensive patients
Conclusions:
Antihypertensive function and inhibitory effects of telmisartan on the T lymphocyte NFAT signalling pathway are unlikely to affect the normal immune function of hypertensive patients. Telmisartan may exert anti-inflammatory effects by inhibition of the NFAT signalling pathway in the T lymphocytes of hypertensive patients.
Source: Journal of the Renin-Angiotensin-Aldosterone System : JRAAS - Category: Biomedical Science Authors: Huang, S.-S., He, S.-L., Zhang, Y.-M. Tags: Original Article Source Type: research
More News: Biomedical Science | Cardiology | Cardiovascular | Heart | Hypertension | Kazakhstan Health | Study